Landscape Capital Management, L.L.C. Reata Pharmaceuticals Inc Transaction History

Landscape Capital Management, L.L.C.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$51.9 - $101.79 $382,139 - $749,479	-7,363 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$48.76 - $76.44 $359,019 - $562,827	7,363 New	7,363 $413,000
Q3 2018 Nov 14, 2018	SELL	$35.64 - $92.06 $752,467 - $1.94 Million	-21,113 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$19.94 - $40.96 $648,568 - $1.33 Million	-32,526 Reduced 60.64%	21,113 $738,000
Q1 2018 May 11, 2018	BUY	$20.0 - $30.19 $747,620 - $1.13 Million	37,381 Added 229.92%	53,639 $1.1 Million
Q4 2017 Feb 13, 2018	BUY	$22.39 - $33.27 $184,896 - $274,743	8,258 Added 103.23%	16,258 $460,000
Q2 2017 Aug 14, 2017	BUY	N/A	8,000	8,000 $253,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.